CN112479484A - Pharmaceutical adjuvant production wastewater treatment process - Google Patents

Pharmaceutical adjuvant production wastewater treatment process Download PDF

Info

Publication number
CN112479484A
CN112479484A CN202011207541.3A CN202011207541A CN112479484A CN 112479484 A CN112479484 A CN 112479484A CN 202011207541 A CN202011207541 A CN 202011207541A CN 112479484 A CN112479484 A CN 112479484A
Authority
CN
China
Prior art keywords
wastewater
sewage
primary
fenton oxidation
acidification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011207541.3A
Other languages
Chinese (zh)
Inventor
黄爱民
袁孟云
范安亿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Zhengda Environmental Technology Consulting Engineering Co ltd
Original Assignee
Henan Zhengda Environmental Technology Consulting Engineering Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Zhengda Environmental Technology Consulting Engineering Co ltd filed Critical Henan Zhengda Environmental Technology Consulting Engineering Co ltd
Priority to CN202011207541.3A priority Critical patent/CN112479484A/en
Publication of CN112479484A publication Critical patent/CN112479484A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F9/00Multistage treatment of water, waste water or sewage
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F11/00Treatment of sludge; Devices therefor
    • C02F11/12Treatment of sludge; Devices therefor by de-watering, drying or thickening
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/24Treatment of water, waste water, or sewage by flotation
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/46Treatment of water, waste water, or sewage by electrochemical methods
    • C02F1/461Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/52Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/66Treatment of water, waste water, or sewage by neutralisation; pH adjustment
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/72Treatment of water, waste water, or sewage by oxidation
    • C02F1/722Oxidation by peroxides
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/72Treatment of water, waste water, or sewage by oxidation
    • C02F1/725Treatment of water, waste water, or sewage by oxidation by catalytic oxidation
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F2001/007Processes including a sedimentation step
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00Biological treatment of water, waste water, or sewage
    • C02F3/02Aerobic processes
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00Biological treatment of water, waste water, or sewage
    • C02F3/28Anaerobic digestion processes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Water Treatment By Electricity Or Magnetism (AREA)

Abstract

The invention relates to the technical field of pharmaceutical excipient production wastewater, in particular to a pharmaceutical excipient production wastewater treatment process, which is used for solving the problems that pollutants in wastewater are difficult to effectively treat and secondary pollution is easily caused when high-concentration pharmaceutical excipient production wastewater is treated in the prior art. The invention comprises the following steps: step 1: removing floating objects; step 2: air floatation; and step 3: adjusting the pH value; and 4, step 4: electrolyzing iron and carbon; and 5: performing primary Fenton oxidation; step 6: primary coagulating sedimentation; and 7: hydrolyzing and acidifying; and 8: biological contact oxidation; and step 9: secondary Fenton oxidation; step 10: and (5) performing secondary coagulating sedimentation. Through the treatment process, various indexes of treated effluent can meet the discharge standard, so that harmful substances in high-concentration pharmaceutical adjuvant production wastewater can be more effectively removed, and secondary pollution can be reduced.

Description

Pharmaceutical adjuvant production wastewater treatment process
Technical Field
The invention relates to the technical field of pharmaceutical excipient production wastewater, and particularly relates to a pharmaceutical excipient production wastewater treatment process.
Background
The pharmaceutic adjuvant is a basic material and an important component of the pharmaceutical preparation and is a material basis for ensuring the production and development of the pharmaceutical preparation. At present, more than 500 pharmaceutical excipients are proposed in China, and because the products are multiple, the production process is diversified, the components of the produced wastewater are more complex, and the wastewater has the characteristics of high concentration, high salinity, difficult biodegradation and the like, so that the wastewater is one of the industrial wastewater which is difficult to treat, and the wastewater produced by the pharmaceutical excipients needs a corresponding wastewater treatment process for better treatment.
The wastewater treatment process in the prior art adopts a pulse filler extraction tower, wastewater of a sartan drug quenching process is taken as a light phase and pumped into the tower from the bottom of the tower, an extracting agent is taken as a heavy phase and pumped into the tower from the top of the tower, continuous extraction is carried out under the conditions that the volume flow ratio of the heavy phase to the light phase is 1:1 and the pulse frequency is 40-100 times/min, the extracted light phase is collected from the top of the tower respectively, and the extracted heavy phase is collected from the bottom of the tower; rectifying the extracted heavy phase to recover the extractant and dimethyl formamide (DMF), wherein the recovery rate of the extractant and the dimethyl formamide is more than 98.0%, the purity is more than 99.0%, and the heavy phase is recycled; adjusting the pH of the extracted light phase to 6-7, decoloring and removing impurities, adding a sodium carbonate aqueous solution, stirring and reacting at 40-70 ℃ for 0.5-3h to remove zinc, filtering at normal temperature to obtain filtrate and filter cake, and drying the filter cake to obtain a basic zinc carbonate byproduct; the zinc value of the filtrate is less than 1mg/L, and the filtrate can be directly merged into a factory sewage system for treatment.
However, in the prior art, the process for treating wastewater from pharmaceutical adjuvant production is difficult to effectively treat the pollutants in the wastewater when treating high-concentration wastewater, and is easy to cause secondary pollution. Therefore, a process for treating wastewater from pharmaceutical adjuvant production, which can effectively remove harmful substances from high-concentration wastewater and reduce secondary pollution, is urgently needed.
Disclosure of Invention
Based on the above problems, the present invention aims to: the utility model provides a pharmaceutical excipients waste water treatment process for solve among the prior art when handling high concentration pharmaceutical excipients waste water effectively handle the pollutant material in the sewage, cause secondary pollution's problem moreover easily. According to the invention, by adopting the treatment process of air floatation, iron carbon electrolysis, primary Fenton oxidation, primary coagulation precipitation, hydrolytic acidification, biological contact oxidation, secondary Fenton oxidation and secondary coagulation precipitation, all indexes of treated effluent can meet the discharge standard, so that harmful substances in high-concentration pharmaceutical adjuvant production wastewater can be more effectively removed, and secondary pollution can be reduced.
The invention specifically adopts the following technical scheme for realizing the purpose:
a process for treating wastewater generated in pharmaceutical adjuvant production comprises the following steps:
step 1: removing floating objects, intercepting the floating objects in the sewage through a grating channel, and periodically cleaning;
step 2: air floatation, namely floating suspended particles in the wastewater on the water surface by utilizing the buoyancy principle through an air floatation machine and removing the suspended particles;
and step 3: adjusting the pH, namely adding acid or alkali into a pH adjusting tank to adjust the pH in the sewage;
and 4, step 4: iron-carbon electrolysis, namely lifting the sewage with the adjusted pH value to an iron-carbon electrolysis reactor through a pump for electrolysis;
and 5: carrying out primary Fenton oxidation, and conveying the electrolyzed sewage into a Fenton oxidation reactor for oxidation treatment;
step 6: primary coagulating sedimentation, namely conveying the wastewater after the primary Fenton oxidation to a primary coagulating sedimentation tank, adding a coagulant and a coagulant aid into the wastewater to ensure that particles which are difficult to precipitate in the wastewater can be mutually polymerized to form colloid, then combining the colloid with impurities in the wastewater to form a flocculating constituent, and removing the flocculating constituent;
and 7: carrying out hydrolytic acidification, conveying the sewage subjected to primary coagulation precipitation into a hydrolytic acidification tank, converting non-soluble organic matters in the sewage into soluble organic matters through hydrolysis, and carrying out fermentation degradation treatment on the soluble organic matters through acidification;
and 8: biological contact oxidation, namely conveying the sewage subjected to hydrolysis and acidification in the step 7 into a biological contact oxidation tank, adsorbing organic matters in the wastewater through a biological membrane, and oxidizing and decomposing the organic matters by microorganisms under the aerobic condition;
and step 9: carrying out secondary Fenton oxidation, namely conveying the sewage subjected to biological contact oxidation into a secondary Fenton oxidation reactor for secondary Fenton oxidation treatment;
step 10: and (4) secondary coagulating sedimentation, namely conveying the wastewater after the secondary Fenton oxidation to a secondary coagulating sedimentation tank, and performing secondary coagulating sedimentation treatment to obtain clear water reaching the standard.
Still be equipped with middle pond between first coagulating sedimentation pond and hydrolysis-acidification pool, low concentration waste water is directly carried the hydrolysis-acidification in the pond through middle pond and is carried out hydrolysis-acidification.
And (3) conveying the sludge subjected to primary coagulation sedimentation and secondary coagulation sedimentation into a sludge storage tank for sludge dewatering treatment, discharging the dewatered dry sludge, and feeding the dewatered water into the step 2 again.
The discharge standard of the clear water discharged in the step 10 is as follows: COD less than or equal to 300mg/L, BOD5≤150mg/L,NH3-N≤30mg/L,SS≤150mg/L。
The invention has the following beneficial effects:
(1) by adopting the treatment process of air flotation, iron carbon electrolysis, primary Fenton oxidation, primary coagulation precipitation, hydrolytic acidification, biological contact oxidation, secondary Fenton oxidation and secondary coagulation precipitation, all indexes of treated effluent can meet the discharge standard, so that harmful substances in high-concentration pharmaceutical adjuvant production wastewater can be more effectively removed, and the process is mature and reliable, stable in operation, easy to operate, capable of reducing secondary pollution and simultaneously reducing pollution of sewage to the ecological environment.
(2) The invention starts to process from step 1 if the wastewater is high-concentration wastewater, and starts to process from step 7 if the wastewater is low-concentration wastewater, so that the targeted processing can reduce the processing cost of the wastewater.
(3) In the invention, the sludge after primary coagulation sedimentation and secondary coagulation sedimentation is conveyed to the sludge storage tank for sludge dehydration treatment, the dehydrated dry sludge is discharged, and the dehydrated water enters the step 2 again, so that the sludge can be effectively utilized, and the water resource in the sludge can be utilized again, thereby greatly saving water resource and soil resource.
Drawings
FIG. 1 is a process flow diagram of the wastewater treatment of pharmaceutical adjuvant production according to the present invention;
Detailed Description
For a better understanding of the present invention by those skilled in the art, the present invention will be described in further detail below with reference to the accompanying drawings and the following examples.
Example (b):
as shown in figure 1, the process for treating the pharmaceutical excipient production wastewater comprises the following steps:
step 1: removing floating objects, intercepting the floating objects in the sewage through a grating channel, and periodically cleaning; the grid channel can be provided with a steel-concrete structure, and the size of the grid channel is 2.0 mx0.5mx1.5m;
step 2: air floatation, namely floating suspended particles in the wastewater on the water surface by utilizing the buoyancy principle through an air floatation machine and removing the suspended particles; an air floatation machine is arranged, and the processing capacity of the air floatation machine is 5m3H, size 1.5mx1.8 m;
and step 3: adjusting the pH, namely adding acid or alkali into a pH adjusting tank to adjust the pH in the sewage; a PH adjusting tank is arranged, and the effective volume of the PH adjusting tank is 5.6m3A size of 1.5 mx1.5mx3m;
and 4, step 4: iron-carbon electrolysis, namely lifting the sewage with the adjusted pH value to an iron-carbon electrolysis reactor through a pump for electrolysis; 2 pumps can be arranged, 1 pump is used for standby, the lift of the pump is 20m, and the power is 0.55 KW;
and 5: carrying out primary Fenton oxidation, and conveying the electrolyzed sewage into a Fenton oxidation reactor for oxidation treatment; arranging a Fenton oxidation reactor;
step 6: primary coagulating sedimentation, namely conveying the wastewater after the primary Fenton oxidation to a primary coagulating sedimentation tank, adding a coagulant and a coagulant aid into the wastewater to ensure that particles which are difficult to precipitate in the wastewater can be mutually polymerized to form colloid, then combining the colloid with impurities in the wastewater to form a flocculating constituent, and removing the flocculating constituent; the primary coagulation sedimentation tank is of a steel-concrete structure, and the size of the primary coagulation sedimentation tank is 2.2 mx2.2mx4m;
and 7: hydrolyzing and acidifying, namely conveying the sewage subjected to primary coagulating sedimentation into a hydrolyzing and acidifying tank, and converting non-soluble organic matters in the sewage into non-soluble organic matters through hydrolysisPerforming fermentation degradation treatment on soluble organic matters through acidification; the effective volume of the hydrolysis acidification tank is 347.2m3And has a size of 8 mx7mx6.5m;
and 8: biological contact oxidation, namely conveying the sewage subjected to hydrolysis and acidification in the step 7 into a biological contact oxidation tank, adsorbing organic matters in the wastewater through a biological membrane, and oxidizing and decomposing the organic matters by microorganisms under the aerobic condition; the biological contact oxidation pond is of a steel-concrete structure, the size of the biological contact oxidation pond can be 10mx5mx5.5m, and the effective volume of the biological contact oxidation pond is 250m3The retention time is 60 hours;
and step 9: carrying out secondary Fenton oxidation, namely conveying the sewage subjected to biological contact oxidation into a secondary Fenton oxidation reactor for secondary Fenton oxidation treatment;
step 10: and (4) secondary coagulating sedimentation, namely conveying the wastewater after the secondary Fenton oxidation to a secondary coagulating sedimentation tank, and performing secondary coagulating sedimentation treatment to obtain clear water reaching the standard. The discharge standard of the discharged clear water is as follows: COD less than or equal to 300mg/L, BOD5≤150mg/L,NH3-N≤30mg/L,SS≤150mg/L。
Preferably, still be equipped with middle pond between initial coagulating sedimentation pond and hydrolysis acidification pond, low concentration waste water is directly carried the hydrolysis acidification pond through middle pond and is carried out the hydrolysis acidification in. If the wastewater is high-concentration wastewater, the treatment is started from the step 1, and if the wastewater is low-concentration wastewater, the treatment is started from the step 7, so that the targeted treatment can be realized, and the treatment cost of the wastewater can be reduced.
Preferably, the sludge after the primary coagulation sedimentation and the secondary coagulation sedimentation is conveyed to a sludge storage tank for sludge dewatering treatment, the dewatered dry sludge is discharged, and the dewatered water enters the step 2 again. Therefore, the sludge can be effectively utilized, and water resources in the sludge can be reused, so that a large amount of water resources and soil resources can be saved.
The treatment effect of the wastewater treated by the process flow is as follows:
Figure BDA0002757600860000041
according to the above table and the actual treatment conditions, by adopting the treatment process of air floatation, iron carbon electrolysis, primary Fenton oxidation, primary coagulation precipitation, hydrolytic acidification, biological contact oxidation, secondary Fenton oxidation and secondary coagulation precipitation, all indexes of the treated effluent can meet the discharge standard, so that harmful substances in the high-concentration pharmaceutical adjuvant production wastewater can be more effectively removed, and the process is mature and reliable, stable in operation, easy to operate, capable of reducing secondary pollution and simultaneously reducing pollution of sewage to the ecological environment.
The above is an embodiment of the present invention. The embodiments and specific parameters in the embodiments are only for the purpose of clearly illustrating the verification process of the invention and are not intended to limit the scope of the invention, which is defined by the claims, and all equivalent structural changes made by using the contents of the specification and the drawings of the present invention should be covered by the scope of the present invention.

Claims (4)

1. A process for treating wastewater generated in pharmaceutical adjuvant production is characterized by comprising the following steps: the method comprises the following steps:
step 1: removing floating objects, intercepting the floating objects in the sewage through a grating channel, and periodically cleaning;
step 2: air floatation, namely floating suspended particles in the wastewater on the water surface by utilizing the buoyancy principle through an air floatation machine and removing the suspended particles;
and step 3: adjusting the pH, namely adding acid or alkali into a pH adjusting tank to adjust the pH in the sewage;
and 4, step 4: iron-carbon electrolysis, namely lifting the sewage with the adjusted pH value to an iron-carbon electrolysis reactor through a pump for electrolysis;
and 5: carrying out primary Fenton oxidation, and conveying the electrolyzed sewage into a Fenton oxidation reactor for oxidation treatment;
step 6: primary coagulating sedimentation, namely conveying the wastewater after the primary Fenton oxidation to a primary coagulating sedimentation tank, adding a coagulant and a coagulant aid into the wastewater to ensure that particles which are difficult to precipitate in the wastewater can be mutually polymerized to form colloid, then combining the colloid with impurities in the wastewater to form a flocculating constituent, and removing the flocculating constituent;
and 7: carrying out hydrolytic acidification, conveying the sewage subjected to primary coagulation precipitation into a hydrolytic acidification tank, converting non-soluble organic matters in the sewage into soluble organic matters through hydrolysis, and carrying out fermentation degradation treatment on the soluble organic matters through acidification;
and 8: biological contact oxidation, namely conveying the sewage subjected to hydrolysis and acidification in the step 7 into a biological contact oxidation tank, adsorbing organic matters in the wastewater through a biological membrane, and oxidizing and decomposing the organic matters by microorganisms under the aerobic condition;
and step 9: carrying out secondary Fenton oxidation, namely conveying the sewage subjected to biological contact oxidation into a secondary Fenton oxidation reactor for secondary Fenton oxidation treatment;
step 10: and (4) secondary coagulating sedimentation, namely conveying the wastewater after the secondary Fenton oxidation to a secondary coagulating sedimentation tank, and performing secondary coagulating sedimentation treatment to obtain clear water reaching the standard.
2. The pharmaceutical excipient production wastewater treatment process according to claim 1, which is characterized in that: still be equipped with middle pond between first coagulating sedimentation pond and hydrolysis-acidification pool, low concentration waste water is directly carried the hydrolysis-acidification in the pond through middle pond and is carried out hydrolysis-acidification.
3. The pharmaceutical excipient production wastewater treatment process according to claim 1, which is characterized in that: and (3) conveying the sludge subjected to primary coagulation sedimentation and secondary coagulation sedimentation into a sludge storage tank for sludge dewatering treatment, discharging the dewatered dry sludge, and feeding the dewatered water into the step 2 again.
4. The pharmaceutical excipient production wastewater treatment process according to claim 1, which is characterized in that: the discharge standard of the clear water discharged in the step 10 is as follows: COD less than or equal to 300mg/L, BOD5≤150mg/L,NH3-N≤30mg/L,SS≤150mg/L。
CN202011207541.3A 2020-11-03 2020-11-03 Pharmaceutical adjuvant production wastewater treatment process Pending CN112479484A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011207541.3A CN112479484A (en) 2020-11-03 2020-11-03 Pharmaceutical adjuvant production wastewater treatment process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011207541.3A CN112479484A (en) 2020-11-03 2020-11-03 Pharmaceutical adjuvant production wastewater treatment process

Publications (1)

Publication Number Publication Date
CN112479484A true CN112479484A (en) 2021-03-12

Family

ID=74926443

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011207541.3A Pending CN112479484A (en) 2020-11-03 2020-11-03 Pharmaceutical adjuvant production wastewater treatment process

Country Status (1)

Country Link
CN (1) CN112479484A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130206692A1 (en) * 2010-10-28 2013-08-15 Shiwen Zhang Tanning wastewater treatment and recycling method based on nano-catalytic electrolysis technology and membrane technology
CN103739150A (en) * 2013-11-15 2014-04-23 安徽省绿巨人环境技术有限公司 Medicinal auxiliary material production wastewater treatment technology
CN104649512A (en) * 2014-12-23 2015-05-27 安徽省天虹绿洲环保科技有限公司 High-concentration medicinal adjuvant wastewater treatment process
CN208995338U (en) * 2018-09-25 2019-06-18 成都渤茂科技有限公司 A kind of processing system of oilfield drilling waste liquid
CN111153565A (en) * 2020-02-26 2020-05-15 广东广深环保科技有限公司 Treatment system and treatment method for esterification wastewater

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130206692A1 (en) * 2010-10-28 2013-08-15 Shiwen Zhang Tanning wastewater treatment and recycling method based on nano-catalytic electrolysis technology and membrane technology
CN103739150A (en) * 2013-11-15 2014-04-23 安徽省绿巨人环境技术有限公司 Medicinal auxiliary material production wastewater treatment technology
CN104649512A (en) * 2014-12-23 2015-05-27 安徽省天虹绿洲环保科技有限公司 High-concentration medicinal adjuvant wastewater treatment process
CN208995338U (en) * 2018-09-25 2019-06-18 成都渤茂科技有限公司 A kind of processing system of oilfield drilling waste liquid
CN111153565A (en) * 2020-02-26 2020-05-15 广东广深环保科技有限公司 Treatment system and treatment method for esterification wastewater

Similar Documents

Publication Publication Date Title
CN101805090B (en) Process for treating fracturing flow-back fluid of oil well
CN103449678A (en) Agricultural equipment coating wastewater treatment technology
CN110713314A (en) Method for treating landfill leachate
CN109437454B (en) Enhanced physicochemical treatment method and device for refined high-salt high-ammonia special oily sewage
CN109912083B (en) Electrochemical detoxification and deep dehydration method for blue algae liquid
CN109553266B (en) Deep dehydration method for blue algae
CN102659281A (en) Treatment method of liquor production wastewater
CN102086078A (en) Method for treating and recycling waste water of steel plants
CN103342442A (en) Integrated biotreatment system and method for PVC (poly vinyl chloride) industrial wastewater
CN103043789A (en) Anaerobic reactor and treatment method of cotton pulp production waste water
CN108773982B (en) Treatment method of high-concentration wastewater
CN111875171B (en) Duck breeding wastewater treatment process and resource recovery method
CN103896457A (en) Fine chemical wastewater treatment process
CN210176681U (en) Landfill leachate nanofiltration concentrated solution treatment system
CN208136048U (en) A kind of vegetables juicing waste water treatment system
CN115872572A (en) Method for treating cleaning degumming wastewater and redundant slicing wastewater
CN111253013A (en) Method and device for treating landfill leachate membrane concentrated solution
CN112479484A (en) Pharmaceutical adjuvant production wastewater treatment process
CN207121472U (en) A kind of aerobic integrated sewage-treating reactor device of internal circulating anaerobic
CN108218146A (en) A kind for the treatment of process and processing system of rubber chemicals class high concentrated organic wastewater
CN209872679U (en) Emulsification waste liquid treatment system
CN210505887U (en) Thermal power plant circulating water blowdown water deep treatment system of municipal reclaimed water source
CN210313930U (en) Chemical wastewater treatment system
CN209906537U (en) Deep dehydration device for blue algae
CN110054353B (en) Garbage incineration power generation leachate treatment system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210312